Inventor · disambiguated record
Miles Carroll
Also filed as: CARROLL MILES · CARROLL MILES W · CARROLL MILES WILLIAM
23 granted patents·24 pending applications·194 citations·filing 1998–2020
95Inventor score
Files withOXFORD BIOMEDICA LTD30CARROLL MILES3HARROP RICHARD2THE SEC DEP FOR HEALTH2CANCER REC TECH LTD1
Top patents by PatentIndex Score
47 records- 0193US7514546B2AntibodiesOXFORD BIOMEDICA LTD·Filed 2006·Granted Apr 7, 2009·13 cites·25 claims
- 0289US8084249B2VectorKINGSMAN SUSAN MARY·Filed 2010·Granted Dec 27, 2011·9 cites·6 claims
- 0388US7148035B1PolypeptideOXFORD BIOMEDICA LTD·Filed 2000·Granted Dec 12, 2006·12 cites·12 claims
- 0488US6312683B1Equine infectious anemia virus vectorsOXFORD BIOMEDICA LTD·Filed 1999·Granted Nov 6, 2001·73 cites·64 claims
- 0586US7666669B2PolypeptideOXFORD BIOMEDICA LTD·Filed 2006·Granted Feb 23, 2010·2 cites·11 claims
- 0686US7531648B2Vector encoding an antibody that binds 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2002·Granted May 12, 2009·8 cites·13 claims
- 0784US7718627B2VectorOXFORD BIOMEDICA LTD·Filed 2006·Granted May 18, 2010·4 cites·24 claims
- 0884US6852703B1Tumor targeted vectorOXFORD BIOMEDICA LTD·Filed 1998·Granted Feb 8, 2005·39 cites·31 claims
- 0983US7601698B2PolypeptideOXFORD BIOMEDICA LTD·Filed 2005·Granted Oct 13, 2009·1 cites·9 claims
- 1082US7910109B2MHC class II epitopes of 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2003·Granted Mar 22, 2011·8 cites·5 claims
- 1180US7615612B2PolypeptideOXFORD BIOMEDICA LTD·Filed 2007·Granted Nov 10, 2009·2 cites·16 claims
- 1278US2010233126A1PolypeptideOXFORD BIOMEDICA INC·Filed 2009·Application pending·0 cites
- 1376US7888115B2MHC class I peptide epitopes from the human 5T4 tumor-associated antigenOXFORD BIOMEDICA LTD·Filed 2009·Granted Feb 15, 2011·1 cites·2 claims
- 1475US7659383B2Feline 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2008·Granted Feb 9, 2010·2 cites·6 claims
- 1575US7541044B2Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigensOXFORD BIOMEDICA LTD·Filed 2006·Granted Jun 2, 2009·2 cites·16 claims
- 1675US7276488B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Oct 2, 2007·2 cites·18 claims
- 1774US9982039B2Mycobacterial antigen compositionTHE SEC DEP OF HEALTH·Filed 2016·Granted May 29, 2018·2 cites·9 claims
- 1873US2010040539A1Vector SystemOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 1971US9339534B2Mycobacterial antigen compositionCARROLL MILES·Filed 2011·Granted May 17, 2016·3 cites·20 claims
- 2071US7635687B2Vector systemOXFORD BIOMEDICA LTD·Filed 2002·Granted Dec 22, 2009·2 cites·7 claims
- 2169US2009017532A1VectorOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 2267US7575916B2Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid moleculeOXFORD BIOMEDICA LTD·Filed 2003·Granted Aug 18, 2009·3 cites·2 claims
- 2367US2005032216A1VectorOXFORD BIOMEDICA LTD·Filed 2004·Application pending·0 cites
- 2465US7662625B2Methods for detecting the differentiation status of cells using 5T4 antigen expressionCANCER REC TECH LTD·Filed 2003·Granted Feb 16, 2010·6 cites·10 claims
- 2564US2010310584A1AntigenOXFORD BIOMEDICA LTD·Filed 2009·Application pending·0 cites
- 2662US2009155290A1AntigenOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 2760US2011052577A1AntibodiesOXFORD BIOMEDICA LTD·Filed 2010·Application pending·0 cites
- 2858US2004265275A1PolypeptideOXFORD BIOMEDICA LTD·Filed 2004·Application pending·0 cites
- 2957US2008175819A1Vector systemOXFORD BIOMEDICA LTD·Filed 2007·Application pending·0 cites
- 3057US2013236479A1AntigenOXFORD BIOMEDICA LTD·Filed 2013·Application pending·0 cites
- 3156US7402666B2Nucleotide encoding canine 5T4 antigenOXFORD BIOMEDICA LTD·Filed 2001·Granted Jul 22, 2008·0 cites·6 claims
- 3256US2008279854A1PolypeptideOXFORD BIOMEDICA LTD·Filed 2008·Application pending·0 cites
- 3355US2006024274A1Retroviral vectorsKINGSMAN ALAN J·Filed 2005·Application pending·0 cites
- 3454US2005175618A15t4 ligandFiled 2002·Application pending·0 cites
- 3553US2009191230A1CascadeOXFORD BIOMEDICA LTD·Filed 2006·Application pending·0 cites
- 3653US2003147907A1Retroviral vectorsFiled 2001·Application pending·0 cites
- 3751US8133681B2Chemo-immunotherapy methodHARROP RICHARD·Filed 2008·Granted Mar 13, 2012·0 cites·5 claims
- 3851US2011165668A1MHC Class I Peptide Epitopes from the Human 5T4 Tumor-Associated AntigenOXFORD BIOMEDICA LTD·Filed 2011·Application pending·0 cites
- 3947US2006265773A1Methods for producing transgenic animals with modified disease resistanceCARROLL MILES·Filed 2006·Application pending·0 cites
- 4046US2004096864A1Method of eukaryotic expression cloning of disease associated moleculesFiled 2002·Application pending·0 cites
- 4146US2012213822A1Chemo-immunotherapy methodHARROP RICHARD·Filed 2012·Application pending·0 cites
- 4245US2022275346A1Hantavirus antigenic compositionSEC DEP FOR HEALTH AND SOCIAL CARE·Filed 2020·Application pending·0 cites
- 4343US2005100958A15T4 antigen expressionFiled 2003·Application pending·0 cites
- 4442US10519219B2Filovirus therapyTHE SEC DEP FOR HEALTH·Filed 2016·Granted Dec 31, 2019·0 cites·19 claims
- 4542US2010158884A1CascadeOXFORD BIOMEDICA LTD·Filed 2010·Application pending·0 cites
- 4641US2013217116A1Peptide IICARROLL MILES·Filed 2011·Application pending·0 cites
- 4730US2017144969A1Antimicrobial conjugates, method for production and uses thereofTHE SEC DEP FOR HEALTH·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →